Economic Impact of IPF

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

A recent study outlines how artificial intelligence advancements are transforming research and therapeutic strategies for idiopathic pulmonary fibrosis.

July 24th 2025

PCOC 2025 to Bring More Experts, More Engagement Than Ever

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

Listen

September 24th 2025

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Explore cutting-edge discussions on patient-centered oncology, value-based care, AI innovations, and survivorship strategies Thursday and Friday at PCOC 2025 in Nashville.

December 23rd 2024

AML Survival After 3 Years in Remission Comparable With General Population

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

Listen

Cancer survivor practicing yoga in apartment | Image credit: Halfpoint - stock.adobe.com

CSU More Burdensome in Female Patients, Especially in Midlife

Patients with acute myeloid leukemia (AML) in remission for over 3 years experience survival rates comparable with a matched cohort from the general population.

Female patients with chronic spontaneous urticaria consistently experienced a more severe and burdensome disease course compared with their male counterparts. | Image Credit: Cuoregentile - stock.adobe.com

AI-Driven Research Toolkit Links Aging Biology and Fibrotic Disease

Female patients with chronic spontaneous urticaria (CSU) face greater disease severity and burdens, particularly in midlife, a study found.

Related Content

September 27th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

A recent study outlines how artificial intelligence advancements are transforming research and therapeutic strategies for idiopathic pulmonary fibrosis.

July 24th 2025

PCOC 2025 to Bring More Experts, More Engagement Than Ever

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

Listen

September 24th 2025

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Explore cutting-edge discussions on patient-centered oncology, value-based care, AI innovations, and survivorship strategies Thursday and Friday at PCOC 2025 in Nashville.

December 23rd 2024

AML Survival After 3 Years in Remission Comparable With General Population

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

Listen

CSU More Burdensome in Female Patients, Especially in Midlife

Patients with acute myeloid leukemia (AML) in remission for over 3 years experience survival rates comparable with a matched cohort from the general population.